Alphamab Oncology Price Chart
Alphamab Oncology 3NK.F Financial and Trading Overview
| Alphamab Oncology stock price | 0.27 EUR |
| Previous Close | 0.86 EUR |
| Open | 0.98 EUR |
| Bid | 0.96 EUR x N/A |
| Ask | 1.02 EUR x N/A |
| Day's Range | 0.98 - 0.99 EUR |
| 52 Week Range | 0.7 - 1.95 EUR |
| Volume | 7.51K EUR |
| Avg. Volume | 1.03K EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
3NK.F Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Alphamab Oncology Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 1.95 EUR |
| 52 Week Low | 0.7 EUR |
| 50-Day Moving Average | 1.48 EUR |
| 200-Day Moving Average | 1.3 EUR |
3NK.F Share Statistics
| Avg. Volume (3 month) | 1.03K EUR |
| Avg. Daily Volume (10-Days) | 28 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Alphamab Oncology Stock
What is a current 3NK.F stock price?
Alphamab Oncology 3NK.F stock price today per share is 0.27 EUR.
How to purchase Alphamab Oncology stock?
You can buy 3NK.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alphamab Oncology?
The stock symbol or ticker of Alphamab Oncology is 3NK.F.
How many shares does Alphamab Oncology have in circulation?
The max supply of Alphamab Oncology shares is 1.11B.
What is Alphamab Oncology Price to Earnings Ratio (PE Ratio)?
Alphamab Oncology PE Ratio is now.
What was Alphamab Oncology earnings per share over the trailing 12 months (TTM)?
Alphamab Oncology EPS is 0 EUR over the trailing 12 months.